SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
猜猜我是谁
Lv1
53 积分
2021-03-20 加入
最近求助
最近应助
互助留言
特应性皮炎患者的临床特征及治疗需求分析
12小时前
待确认
Clinical pathway for the diagnosis and treatment of moderate to severe atopic dermatitis in China (2023): an expert consensus
3天前
已完结
Consensus on the whole-process management of atopic dermatitis
8天前
已完结
Dupilumab provides sustained effectiveness on patient-reported outcomes and favorable safety in patients with moderate-to-severe atopic dermatitis: up to 5-year results from the daily practice BioDay Registry
10天前
已完结
Treatment Patterns and Outcomes in Resected Early-stage Non-small Cell Lung Cancer: An Analysis of the SEER-Medicare Data
12天前
已完结
Tirzepatide versus insulin glargine as second-line or third-line therapy in type 2 diabetes in the Asia-Pacific region: the SURPASS-AP-Combo trial
12天前
已完结
Upadacitinib treatment withdrawal and retreatment in patients with moderate‐to‐severe atopic dermatitis: Results from a phase 2b, randomized, controlled trial
13天前
已完结
Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib in moderate-to-severe atopic dermatitis: results from an open-label extension of the phase 3, randomized, controlled trial (Heads Up)
13天前
已完结
Differential dynamics of TARC during JAK‐inhibitor therapy compared to biological therapies targeting type 2 inflammation
13天前
已完结
Biologic and Small Molecule Therapy for Treating Moderate to Severe Atopic Dermatitis: Mechanistic Considerations
13天前
已完结
没有进行任何应助
已找到【积分已退回】
2个月前
已找到【积分已退回】
3个月前
标题错误
3个月前
doi错误
11个月前
已找到【积分已退回】
1年前
已找到【积分已退回】
1年前
已找到【积分已退回】
1年前
已找到【积分已退回】
1年前
标题错误
1年前
标题错误
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论